These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24100090)

  • 1. Maintaining patency in totally implantable venous access devices (TIVAD): a time-to-event analysis of different lock irrigation intervals.
    Palese A; Baldassar D; Rupil A; Bonanni G; Capellari Maria T; Contessi D; De Crignis L; Vidoni A; Piller Roner S; Zanini A
    Eur J Oncol Nurs; 2014 Feb; 18(1):66-71. PubMed ID: 24100090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
    Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
    Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prolonged flushing interval in totally implantable venous access devices (TIVADs).
    Rasero L; Golin L; Ditta S; Di Massimo DS; Dal Molin A; Piemonte G
    Br J Nurs; 2018 Apr; 27(8):S4-S10. PubMed ID: 29683741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of functional complications of totally implantable venous access devices by an advanced practice nursing team: 5 years of clinical experience.
    Goossens GA; Stas M; Moons P
    Eur J Oncol Nurs; 2012 Dec; 16(5):465-71. PubMed ID: 22265937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal saline versus heparin solution to lock totally implanted venous access devices: Results from a multicenter randomized trial.
    Dal Molin A; Clerico M; Baccini M; Guerretta L; Sartorello B; Rasero L
    Eur J Oncol Nurs; 2015 Dec; 19(6):638-43. PubMed ID: 25933709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Totally implantable central venous access ports in patients with cystic fibrosis: a multicenter prospective cohort study.
    Dal Molin A; Di Massimo DS; Braggion C; Bisogni S; Rizzi E; D'Orazio C; Di Toppa MV; Alghisi F; Cristadoro S; Carnovale V; Festa G; Rampini S; Colombo C; Oneta A; Furnari ML; Calamia MA; Zunino ML; Tuccio G; Spadea V; Messore B; Grosso B; Festini F
    J Vasc Access; 2012; 13(3):290-5. PubMed ID: 22266592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
    Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
    J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and safety of endovascular stripping of totally implantable venous access devices.
    Heye S; Maleux G; Goossens GA; Vaninbroukx J; Jerôme M; Stas M
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):607-12. PubMed ID: 21479744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous bacterial colonization, modalities of chemotherapeutic infusion, and catheter-related bloodstream infection in totally implanted venous access devices.
    Laurenzi L; Natoli S; Benedetti C; Marcelli ME; Tirelli W; DiEmidio L; Arcuri E
    Support Care Cancer; 2004 Nov; 12(11):805-9. PubMed ID: 15372220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical review and analysis of complications of totally implantable venous access devices for chemotherapy.
    Kim JT; Oh TY; Chang WH; Jeong YK
    Med Oncol; 2012 Jun; 29(2):1361-4. PubMed ID: 21380779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External jugular vein cutdown approach, as a useful alternative, supports the choice of the cephalic vein for totally implantable access device placement.
    Di Carlo I; Barbagallo F; Toro A; Sofia M; Lombardo R; Cordio S
    Ann Surg Oncol; 2005 Jul; 12(7):570-3. PubMed ID: 15889215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of totally implantable venous access devices.
    Wang YC; Lin PL; Chou WH; Lin CP; Huang CH
    Support Care Cancer; 2017 Jul; 25(7):2049-2054. PubMed ID: 28181014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients.
    Bertoglio S; Solari N; Meszaros P; Vassallo F; Bonvento M; Pastorino S; Bruzzi P
    Cancer Nurs; 2012; 35(4):E35-42. PubMed ID: 22228390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased use of percutaneous technique for totally implantable venous access devices. Is it real progress? A 27-year comprehensive review on early complications.
    Di Carlo I; Pulvirenti E; Mannino M; Toro A
    Ann Surg Oncol; 2010 Jun; 17(6):1649-56. PubMed ID: 20204533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality-of-life assessment: arm TIVAD versus chest TIVAD.
    Burbridge B; Goyal K
    J Vasc Access; 2016 Nov; 17(6):527-534. PubMed ID: 27768211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The catheter is stuck: complications experienced during removal of a totally implantable venous access device. A single-center study in 200 children.
    Wilson GJ; van Noesel MM; Hop WC; van de Ven C
    J Pediatr Surg; 2006 Oct; 41(10):1694-8. PubMed ID: 17011271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis.
    Ghayyda SN; Roland D; Cade A
    J Cyst Fibros; 2008 Sep; 7(5):448-9. PubMed ID: 18455967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients.
    Rabe C; Gramann T; Sons X; Berna M; González-Carmona MA; Klehr HU; Sauerbruch T; Caselmann WH
    Intensive Care Med; 2002 Aug; 28(8):1172-6. PubMed ID: 12185445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
    Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M
    Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right or left? Side selection for a totally implantable vascular access device: a randomised observational study.
    Lin WY; Lin CP; Hsu CH; Lee YH; Lin YT; Hsu MC; Shao YY
    Br J Cancer; 2017 Sep; 117(7):932-937. PubMed ID: 28787431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.